EV Biologics (EV Biologics) COGS-to-Revenue : 0.56 (As of Dec. 2017)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics COGS-to-Revenue?

EV Biologics's Cost of Goods Sold for the three months ended in Dec. 2017 was $21.82 Mil. Its Revenue for the three months ended in Dec. 2017 was $38.72 Mil.

EV Biologics's COGS to Revenue for the three months ended in Dec. 2017 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. EV Biologics's Gross Margin % for the three months ended in Dec. 2017 was 43.65%.

EV Biologics COGS-to-Revenue Historical Data

The historical data trend for EV Biologics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics COGS-to-Revenue Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

COGS-to-Revenue

0.63

0.62

0.64

0.61

0.80

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
COGS-to-Revenue	Get a 7-Day Free Trial												0.65	0.68	0.61	-	0.56

EV Biologics COGS-to-Revenue Calculation

EV Biologics's COGS to Revenue for the fiscal year that ended in Jun. 2017 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.611	/	9.507
	=	0.80

EV Biologics's COGS to Revenue for the quarter that ended in Dec. 2017 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	21.821	/	38.723
	=	0.56

EV Biologics (OTCPK:YECO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

EV Biologics's Gross Margin % for the three months ended in Dec. 2017 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	21.821 / 38.723
	=	43.65 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

EV Biologics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of EV Biologics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » COGS-to-Revenue

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3